Clinical trial
Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular…
NCT00396682 · Hannover Medical School, Other · Completed
Key facts
| NCT number | NCT00396682 |
|---|---|
| Title | Elimination of CD4+CD25+ Regulatory T Cells in Patients With Hepatocellular Carcinoma |
| Official title | Elimination of CD4+CD25+ Regulatory T Cells in Patients With Advanced HCC After Treatment With Cyclophosphamide |
| Lead sponsor | Hannover Medical School, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Advanced HCC |
| Intervention type | Drug |
| Interventions | Cyclophosphamide |
| Enrollment | 12 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Nov 7, 2006 |
| Last update posted | Feb 4, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: